Article
Farnesyl Transferase Inhibition for the Treatment of Tauopathies
2018-12-18
Abstract excerpt
Tau inclusions are a shared feature of many neurodegenerative conditions and tau mutations lead to frontotemporal dementia. Approaches to treatment of these conditions have focused directly on the tau protein by targeting its post-translational modifications, its levels and its tendency to aggregate. We discovered a novel regulatory pathway for tau degradation that operates through the Rhes protein, a GTPase. Rhes...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 349089c5-6777-51e2-8328-c168e93a1324
- DOI
- 10.1101/500801
